http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008010579-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67d6a77671102af66dfefbbfaf44116a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91693aa530129ef9ce9e70663a374030
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537
filingDate 2008-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f5b88518350783997db5c17d28ef67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5002b6cec4e8a3e3eda4816c25f1df04
publicationDate 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-102008010579-A1
titleOfInvention Combination preparation for topical use
abstract Described is a combination preparation for topical application, in particular as an agent for the treatment of atopic dermatitis. The object of the invention is to provide a preparation, inter alia, but not exclusively, for the treatment of atopic dermatitis, in which the dose of glucocorticoid can be reduced by at least 10% in comparison with previously used preparations, and thus the side effects of the glucocorticoids without reducing the effect of the product on these previously used preparations. The invention is characterized in that the proposed combination preparation for topical application as main components at least - a synthetic glucocorticoid - Salvia extract of Salvia officinalis and - a suitable basis includes.
priorityDate 2008-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007116664-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6322825-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2758
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID38868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483994
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID38868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65126
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281792
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID261491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442009

Total number of triples: 39.